Journal of Neuro-Oncology

, Volume 99, Issue 2, pp 295–296 | Cite as

Early CNS relapse in a good-risk primary mediastinal large B-cell lymphoma after combined chemo- and radio-therapy

  • Makoto Sasaki
  • Koichi Sugimoto
  • Azuchi Masuda
  • Yutaka Tsukune
  • Yuriko Yahata
  • Norio Komatsu
Letter to the Editor
First Online:
Received:
Accepted:

Keywords

Mediastinal Tumor Ommaya Reservoir Mediastinal Radiation Immunoglobulin Heavy Chain Gene Anterior Mediastinal Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Hill QA, Owen RG (2006) CNS prophylaxis in lymphoma: who to target and what therapy to use. Blood Rev 20:319–332CrossRefPubMedGoogle Scholar
  2. 2.
    Zinzani PL, Martelli M, Poletti V et al (2008) Practice guidelines for the management of extranodal non-Hodgkin’s lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation. Haematologica 93:1364–1371. doi: 10.3324/haematol.12742 CrossRefPubMedGoogle Scholar
  3. 3.
    van Besien K, Gisselbrecht C, Pfreundschuh M et al (2008) Secondary lymphomas of the central nervous system: risk, prophylaxis and treatment. Leuk Lymphoma 49(Suppl 1):52–58. doi: 10.1080/10428190802311458 CrossRefPubMedGoogle Scholar
  4. 4.
    McMillan A (2005) Central nervous system-directed preventative therapy in adults with lymphoma. Br J Haematol 131:13–21. doi: 10.1111/j.1365-2141.2005.05703.x CrossRefPubMedGoogle Scholar
  5. 5.
    Bishop PC, Wilson WH, Pearson D et al (1999) CNS involvement in primary mediastinal large B-cell lymphoma. J Clin Oncol 17:2479–2485PubMedGoogle Scholar
  6. 6.
    Kirn D, Mauch P, Shaffer K et al (1993) Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients. J Clin Oncol 11:1336–1343PubMedGoogle Scholar
  7. 7.
    Todeschini G, Ambrosetti A, Meneghini V et al (1990) Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients. J Clin Oncol 8:804–808PubMedGoogle Scholar
  8. 8.
    Lazzarino M, Orlandi E, Paulli M et al (1993) Primary mediastinal B-cell lymphoma with sclerosis: an aggressive tumor with distinctive clinical and pathologic features. J Clin Oncol 11:2306–2313PubMedGoogle Scholar
  9. 9.
    Stefoni V, Broccoli A, Pellegrini C et al (2009) CNS recurrence of primary mediastinal large b-cell lymphoma after complete remission. J Neurooncol 95:135–139. doi: 10.1007/s11060-009-9898-0 CrossRefPubMedGoogle Scholar
  10. 10.
    Tomita N, Kodama F, Kanamori H et al (2002) Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-Hodgkin lymphoma. Cancer 95:576–580. doi: 10.1002/cncr.10699 CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2010

Authors and Affiliations

  • Makoto Sasaki
    • 1
  • Koichi Sugimoto
    • 1
  • Azuchi Masuda
    • 1
  • Yutaka Tsukune
    • 1
  • Yuriko Yahata
    • 1
  • Norio Komatsu
    • 1
  1. 1.Division of Hematology, Department of Internal MedicineJuntendo University School of MedicineTokyoJapan

Personalised recommendations